Cme Group Stock One Year Return
| MX4A Stock | EUR 224.65 2.35 1.04% |
CME Group fundamentals help investors to digest information that contributes to CME's financial success or failures. It also enables traders to predict the movement of CME Stock. The fundamental analysis module provides a way to measure CME's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CME stock.
CME |
CME Group Company One Year Return Analysis
CME's One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
More About One Year Return | All Equity Analysis
One Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
| Competition |
Based on the recorded statements, CME Group has an One Year Return of 0.0%. This indicator is about the same for the Financial Services average (which is currently at 0.0) sector and about the same as Financial Exchanges (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
CME Fundamentals
| Return On Equity | 0.0992 | |||
| Return On Asset | 0.0101 | |||
| Profit Margin | 0.54 % | |||
| Operating Margin | 0.60 % | |||
| Current Valuation | 60.85 B | |||
| Shares Outstanding | 359.72 M | |||
| Shares Owned By Insiders | 0.45 % | |||
| Shares Owned By Institutions | 88.31 % | |||
| Price To Earning | 35.53 X | |||
| Price To Book | 2.16 X | |||
| Price To Sales | 12.30 X | |||
| Revenue | 5.02 B | |||
| Gross Profit | 5.01 B | |||
| EBITDA | 4.02 B | |||
| Net Income | 2.69 B | |||
| Cash And Equivalents | 1.02 B | |||
| Cash Per Share | 2.86 X | |||
| Total Debt | 3.42 B | |||
| Debt To Equity | 15.30 % | |||
| Current Ratio | 1.05 X | |||
| Book Value Per Share | 74.89 X | |||
| Cash Flow From Operations | 3.06 B | |||
| Earnings Per Share | 6.98 X | |||
| Price To Earnings To Growth | 4.38 X | |||
| Target Price | 221.47 | |||
| Number Of Employees | 3.46 K | |||
| Beta | 0.41 | |||
| Market Capitalization | 62.87 B | |||
| Total Asset | 174.18 B | |||
| Z Score | 10.8 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.84 % | |||
| Net Asset | 174.18 B | |||
| Last Dividend Paid | 4.0 |
About CME Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CME Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CME using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CME Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in CME Stock
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.